| Structural basis for selectivity and antagonism in extracellular GPCR-nanobodies RR Schlimgen, FC Peterson, R Heukers, MJ Smit, JD McCorvy, ... Nature Communications 15 (1), 4611, 2024 | 7 | 2024 |
| The non-ELR CXC chemokine encoded by human cytomegalovirus UL146 genotype 5 contains a C-terminal β-hairpin and induces neutrophil migration as a selective CXCR2 agonist C Berg, MJ Wedemeyer, M Melynis, RR Schlimgen, LH Hansen, ... PLoS Pathogens 18 (3), e1010355, 2022 | 5 | 2022 |
| Fragment-based drug discovery of small molecule ligands for the human chemokine CCL28 AL Zhou, DR Jensen, FC Peterson, MA Thomas, RR Schlimgen, ... SLAS Discovery 28 (4), 163-169, 2023 | 3 | 2023 |
| Structural Basis of Nanobody Induced ACKR3 Inhibition R Schlimgen, F Peterson, R Heukers, M Smit, J McCorvy, B Volkman The FASEB Journal 36, 2022 | 1 | 2022 |
| Molecular basis for chemokine recognition and activation of XCR1 X Zhang, RR Schlimgen, S Singh, MP Tomani, BF Volkman, C Zhang Proceedings of the National Academy of Sciences 121 (48), e2405732121, 2024 | | 2024 |
| Constitutive activity of an atypical chemokine receptor revealed by inverse agonistic nanobodies CV Perez Almeria, O Otun, R Schlimgen, TD Lamme, C Crudden, ... bioRxiv, 2024.11. 04.621790, 2024 | | 2024 |
